Selected patients may choose a personalized C-ACT protocol that include low-dose chemotherapy. However, for patients who have become resistant to chemo drugs that were previously effective, Oasis of Hope employs a strategy known as epigenetic therapy which involves the safe drug, to re-establish treatment sensitivity.
Patients on the C-ACT also receive several courses of intravenous vitamin C therapy to kill more of the cancer cells with severe tumor-specific oxidative stress.
For patients who do not elect to have chemotherapy or for whom chemotherapy would appear to be a poor option, the alternative protocol offers a more intense series of intravenous vitamin C sessions.
Intravenous vitamin C therapy at Oasis is distinguished by novel adjunctive features such as ozone autohemotherapy and perfect administration of vitamin to boost tumor oxygenation and catalyze oxidant generation and maximize cancer killing cells.